59 related articles for article (PubMed ID: 38622664)
1. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression.
Khan AA; Liu X; Yan X; Tahir M; Ali S; Huang H
Cancer Metastasis Rev; 2021 Mar; 40(1):245-272. PubMed ID: 33423164
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma.
Qian Y; Gong Y; Fan Z; Luo G; Huang Q; Deng S; Cheng H; Jin K; Ni Q; Yu X; Liu C
J Hematol Oncol; 2020 Oct; 13(1):130. PubMed ID: 33008426
[TBL] [Abstract][Full Text] [Related]
3. Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer.
Araki T; Miwa N
BMC Res Notes; 2024 Apr; 17(1):106. PubMed ID: 38622664
[TBL] [Abstract][Full Text] [Related]
4. Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.
Hosein AN; Dangol G; Okumura T; Roszik J; Rajapakshe K; Siemann M; Zaid M; Ghosh B; Monberg M; Guerrero PA; Singhi A; Haymaker CL; Clevers H; Abou-Elkacem L; Woermann SM; Maitra A
Gastroenterology; 2022 Apr; 162(4):1303-1318.e18. PubMed ID: 34973294
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract][Full Text] [Related]
6. Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation.
Zhou X; Sun Z; Zhang M; Qu X; Yang S; Wang L; Jing Y; Li L; Deng W; Liu F; Di J; Chen J; Wu J; Zhang H
Animal Model Exp Med; 2022 Feb; 5(1):61-71. PubMed ID: 35229994
[TBL] [Abstract][Full Text] [Related]
7. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
;
Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy epigenomic profiling for cancer subtyping.
Baca SC; Seo JH; Davidsohn MP; Fortunato B; Semaan K; Sotudian S; Lakshminarayanan G; Diossy M; Qiu X; El Zarif T; Savignano H; Canniff J; Madueke I; Saliby RM; Zhang Z; Li R; Jiang Y; Taing L; Awad M; Chau CH; DeCaprio JA; Figg WD; Greten TF; Hata AN; Hodi FS; Hughes ME; Ligon KL; Lin N; Ng K; Oser MG; Meador C; Parsons HA; Pomerantz MM; Rajan A; Ritz J; Thakuria M; Tolaney SM; Wen PY; Long H; Berchuck JE; Szallasi Z; Choueiri TK; Freedman ML
Nat Med; 2023 Nov; 29(11):2737-2741. PubMed ID: 37865722
[TBL] [Abstract][Full Text] [Related]
9. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer.
Xu Y; Zhu Q
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902253
[TBL] [Abstract][Full Text] [Related]
10. Epigenome-wide association analysis of pancreatic exocrine cells from high-fat- and normal diet-fed mice and its potential use for understanding the oncogenesis of human pancreatic cancer.
Araki T; Nagashima M; Hirasawa H; Tamalu F; Katagiri Y; Miwa N
Biochem Biophys Res Commun; 2022 Dec; 637():50-57. PubMed ID: 36375250
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation analysis of KRAS mutant cell lines.
Tew BY; Durand JK; Bryant KL; Hayes TK; Peng S; Tran NL; Gooden GC; Buckley DN; Der CJ; Baldwin AS; Salhia B
Sci Rep; 2020 Jun; 10(1):10149. PubMed ID: 32576853
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.
Orth M; Metzger P; Gerum S; Mayerle J; Schneider G; Belka C; Schnurr M; Lauber K
Radiat Oncol; 2019 Aug; 14(1):141. PubMed ID: 31395068
[TBL] [Abstract][Full Text] [Related]
13. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Krishnamurthy N; Kurzrock R
Cancer Treat Rev; 2018 Jan; 62():50-60. PubMed ID: 29169144
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
